Plaque psoriasis Trials in Plainfield, United States
Conditions / Plaque psoriasis / Plainfield, United States
Plaque psoriasis has been the subject of sustained clinical investigation across multiple research sites.
29 total trials for this combination
Showing top 10 of 29 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04053387 | Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003) | COMPLETED | PHASE3 |
| NCT06095115 | A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03573323 | A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis | COMPLETED | PHASE4 |
| NCT05272150 | Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis | COMPLETED | PHASE3 |
| NCT06934226 | A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05223868 | A Study of JNJ-77242113 in Participants With Moderate-to-severe Plaque Psoriasis | COMPLETED | PHASE2 |
| NCT06588738 | A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001 | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT06143878 | A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT06846541 | Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT02134210 | Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO) | COMPLETED | PHASE3 |